# CATNON (NCT00626990)

> Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00626990
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
- Conditions: Brain and Central Nervous System Tumors
- Interventions: temozolomide; DNA methylation analysis; laboratory biomarker analysis; adjuvant therapy; quality-of-life assessment; radiation therapy
- Enrollment: 751
- Primary outcome: Overall Survival as Measured From the Day of Randomization

## Commentary we found

- X threads: 13
- YouTube: 9
- Podcasts: 9

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=catnon-nct00626990

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00626990", "email": "<work email>"}; the inbox owner confirms by the emailed link.